Telephone
1.952.818.8400
Address
400 Gateway Boulevard Burnsville, MN 55337
Description
Imricor Medical Systems, Inc. is a medical device company, which engages in the design, manufacture, and distribution of magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures. The firm offers the Advantage-MR EP Recorder/Stimulator system, an electrophysiology amplifier and recording system with integrated cardiac stimulator, Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter, and Vision-MR Dispersive Electrode, an ablation dispersive electrode that is used to minimize eddy currents induced on the conductive pads during MR scanning. It also performs contract research, as well as licenses its intellectual property for use in implantable devices. The company was founded by Steven Wedan in 2006 and is headquartered in Burnsville, MN.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.41 - 1.71
Trade Value (12mth)
US$30,092.00
1 week
6.6%
1 month
-2.85%
YTD
5.5%
1 year
174.11%
All time high
2.85
EPS 3 yr Growth
-9.20%
EBITDA Margin
%
Operating Cashflow
-$16m
Free Cash Flow Return
-206.50%
ROIC
-393.70%
Interest Coverage
-766.30
Quick Ratio
7.20
Shares on Issue (Fully Dilluted)
236m
HALO Sector
Healthcare
Next Company Report Date
25-Feb-26
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.10
Date | Announcements |
---|---|
28 March 25 |
Cleansing Notice
×
Cleansing Notice |
27 March 25 |
Application for quotation of securities - IMR
×
Application for quotation of securities - IMR |
26 March 25 |
Application for quotation of securities - IMR
×
Application for quotation of securities - IMR |
20 March 25 |
Successful Completion of A$70 Million Capital Raise
×
Successful Completion of A$70 Million Capital Raise |
20 March 25 |
Proposed issue of securities - IMR
×
Proposed issue of securities - IMR |
20 March 25 |
Equity Raising Presentation
×
Equity Raising Presentation |
20 March 25 |
Reinstatement to Official Quotation
×
Reinstatement to Official Quotation |
19 March 25 |
Suspension from Quotation
×
Suspension from Quotation |
17 March 25 |
Trading Halt
×
Trading Halt |
07 March 25 |
S&P DJI Announces March 2025 Quarterly Rebalance
×
S&P DJI Announces March 2025 Quarterly Rebalance |
04 March 25 |
Submission of Second Module to FDA for PMA Products
×
Submission of Second Module to FDA for PMA Products |
27 February 25 |
Appendix 4E and FY24 Financial Accounts
×
Appendix 4E and FY24 Financial Accounts |
27 February 25 |
Imricor Releases FY24 Results
×
Imricor Releases FY24 Results |
27 February 25 |
FY24 Results Investor Presentation
×
FY24 Results Investor Presentation |
19 February 25 |
CE Mark Approval for 2nd Gen Vision MR Ablation Catheter
×
CE Mark Approval for 2nd Gen Vision MR Ablation Catheter |
17 February 25 |
FY24 Results Webinar
×
FY24 Results Webinar |
07 February 25 |
Application for quotation of securities - IMR
×
Application for quotation of securities - IMR |
07 February 25 |
Cleansing Notice
×
Cleansing Notice |
31 January 25 |
Release from Voluntary Escrow
×
Release from Voluntary Escrow |
23 January 25 |
Imricor Q4 CY24 Quarterly Activities Report and Appendix 4C
×
Imricor Q4 CY24 Quarterly Activities Report and Appendix 4C |
13 January 25 |
Notification regarding unquoted securities - IMR
×
Notification regarding unquoted securities - IMR |
09 January 25 |
Notification of cessation of securities - IMR
×
Notification of cessation of securities - IMR |
31 December 24 |
Clarification Announcement
×
Clarification Announcement |
30 December 24 |
Imricor Received First Purchase Order in the Middle East
×
Imricor Received First Purchase Order in the Middle East |
23 December 24 |
NorthStar Regulatory Update
×
NorthStar Regulatory Update |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.